The global direct-to-consumer genetic testing market was valued at USD 1,405 million in 2021 to USD 3,559 million by 2028, progressing at a CAGR of 14.2% from 2022 to 2028, according to Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global direct-to-consumer genetic testing market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the direct-to-consumer genetic testing industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the technology, application, delivery format, and region. The global market for direct-to-consumer genetic testing can be segmented by technology: genotyping arrays, polymerase chain reaction (PCR), sequencing. Globally, the genotyping arrays segment made up the largest share of the direct-to-consumer genetic testing market. Direct-to-consumer genetic testing market is further segmented by application: ancestry, health and wellness. The ancestry segment captured the largest share of the market in 2021. Based on delivery format, the direct-to-consumer genetic testing market is segmented into: test kits, virtual tests. According to the research, the test kits segment had the largest share in the global direct-to-consumer genetic testing market. On the basis of region, the direct-to-consumer genetic testing market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America held the largest revenue share in 2021.

By technology:
– genotyping arrays
– polymerase chain reaction (PCR)
– sequencing

By application:
– ancestry
– health and wellness

By delivery format:
– test kits
– virtual tests

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The global direct-to-consumer genetic testing market report offers detailed information on several market vendors, including Ambry Genetics Corporation, Ancestry.com Inc., Berry Genomics Co., Ltd., BGI Group, Dante Labs Inc., DnaNudge Ltd., Fulgent Genetics, Inc., Gene by Gene Ltd., Genetic Technologies Limited, Illumina Inc., LabGenomics Co., Ltd., Lineagen, Inc., Macrogen, Inc., Myriad Genetics, Inc., Oxford Nanopore Technologies Limited, Pathway Genomics Corp., Quest Diagnostics, Inc., Theragen Etex Co., Ltd., Thermo Fisher Scientific Inc., among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global direct-to-consumer genetic testing market.
– To classify and forecast the global direct-to-consumer genetic testing market based on technology, application, delivery format, region.
– To identify drivers and challenges for the global direct-to-consumer genetic testing market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global direct-to-consumer genetic testing market.
– To identify and analyze the profile of leading players operating in the global direct-to-consumer genetic testing market.

Why Choose This Report
– Gain a reliable outlook of the global direct-to-consumer genetic testing market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.